About Chronix Biomedical
Chronix Biomedical is a company based in San Jose (United States) founded in 1997 was acquired by OncoCyte in February 2021. Chronix Biomedical has raised $21.59 million across 9 funding rounds from investors including OncoCyte, Limitless Earth and Pentagram. The company has 2 employees as of December 31, 2022. Chronix Biomedical operates in a competitive market with competitors including Guardant Health, GRAIL, Color, Thrive Earlier Detection and Delfi Diagnostics, among others.
- Headquarter San Jose, United States
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chronix Biomedical Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Chronix Biomedical
Unlock access to complete
Funding Insights of Chronix Biomedical
Chronix Biomedical has successfully raised a total of $21.59M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $100 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Chronix Biomedical
Chronix Biomedical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include OncoCyte, Limitless Earth and Pentagram.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology companies are invested in by the private equity firm.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided to innovative technology startups.
|
Locked | Locked | Locked | |
|
Brand design services are provided globally by Pentagram.
|
Locked | Locked | Locked |
Investor details for Chronix Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chronix Biomedical
Investment portfolio details for Chronix Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chronix Biomedical
Detailed financials for Chronix Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chronix Biomedical Comparisons
Peer comparison for Chronix Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chronix Biomedical
Chronix Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Color, Thrive Earlier Detection and Delfi Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing for cancer detection
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
Detailed competitors of Chronix Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chronix Biomedical
Complete news archive for Chronix Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chronix Biomedical
Chronix Biomedical was founded in 1997 and raised its 1st funding round 11 years after it was founded.
Chronix Biomedical is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Chronix Biomedical is a funded company, having raised a total of $21.59M across 9 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Chronix Biomedical is 2.
Chronix Biomedical was founded in 1997 in San Jose, United States, within the biomedical sector. Focus is placed on non-invasive diagnostics for cancer, including the Second Opinion blood test used alongside PSA screening to minimize false positives in prostate cancer cases. Development also includes a biomarker test for detecting minimal residual disease following chemotherapy treatments. Operations center on advancing these diagnostic tools for clinical use.
Chronix Biomedical's top competitors include Guardant Health, GRAIL and BillionToOne.
Chronix Biomedical has 4 investors. Key investors include OncoCyte, Limitless Earth, Pentagram, and PrairieGold Venture Partners.